Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azaron
2. Histantin
3. Pyribenzamine
4. Tripelennamine
5. Tripelennamine Citrate
6. Tripelennamine Citrate (1:1)
7. Tripelennamine Maleate
8. Tripelennamine Maleate (1:1)
9. Tripelennamine Monohydrochloride
10. Vetibenzamin
1. 154-69-8
2. Tripelennamine Hcl
3. Ahistamin
4. Dehistin
5. Piristin
6. Pyrinamine
7. Stanzamine
8. Tripelennamine (hydrochloride)
9. Pyribenzamine Hydrochloride
10. Antiallergicum Medivet
11. Dehistin Monohydrochloride
12. Pyribenzamine Monohydrochloride
13. Tripelennamine Monohydrochloride
14. Vetibenzamina
15. Pbz-sr
16. N1-benzyl-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diamine Hydrochloride
17. Pyribenzamine Hcl
18. 22306-05-4
19. Fwv8gj56zn
20. Nsc-409943
21. 154-69-8 (hcl)
22. Smr000058623
23. Mls000069522
24. Mls001148406
25. 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridine Monohydrochloride
26. N-benzyl-n',n'-dimethyl-n-2-pyridyl-ethylenediamine Hydrochloride
27. N,n-dimethyl-n'-(2-pyridyl)-n'-benzylethylenediamine Hydrochloride
28. Tripelennamine Hydrochloride [usp]
29. 1,2-ethanediamine, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, Hydrochloride
30. 1,2-ethanediamine, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, Monohydrochloride
31. 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridine Hydrochloride
32. Recovr
33. N'-benzyl-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine;hydrochloride
34. Tri-tumine
35. Tripelennamine Hydrochloride (usp)
36. N-benzyl-n-[2-(dimethylamino)ethyl]pyridin-2-amine Hydrochloride
37. N,n-dimethyl-n-(phenylmethyl)-n-pyridin-2-ylethane-1,2-diamine Hydrochloride
38. Ccris 1969
39. Re-covr Injectable (veterinary)
40. Sr-01000003013
41. Einecs 205-833-5
42. Unii-fwv8gj56zn
43. Nih 10186
44. Nsc 409943
45. Pyrabenzamine
46. 2-[benzyl[2-(dimethylamino)ethyl]amino]pyridine Hydrochloride
47. Mfcd00012815
48. Tripelennamine Chloride
49. Cpd000058623
50. N-benzyl-n-dimethylaminoethyl Alpha-aminopyridine Hydrochloride
51. Opera_id_1597
52. Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-, Hydrochloride
53. Tripelennaminehydrochloride
54. Tripelenamine Hydrochloride
55. Ethylenediamine, N-benzyl-n',n'-dimethyl-n-(2-pyridyl)-, Hydrochloride
56. Tripelannamine Hydrochloride
57. N-benzyl-n-alpha-pyridyl-n',n'-dimethyl-aethylendiamin-hydrochlorid [german]
58. Pbz-sr (tn)
59. N(sup 1)-alpha-pyridyl-n(sup 1)-benzyl-n,n-dimethyl Ethylenediamine Monohydrochloride
60. Schembl98916
61. Mls000758254
62. Mls001423999
63. Chloropyramine Impurity 1 Hcl
64. Chembl1200446
65. Dtxsid6026248
66. Pyristine (pristina) Hydrochloride
67. N-benzyl-n-alpha-pyridyl-n',n'-dimethyl-aethylendiamin-hydrochlorid
68. Nsc409943
69. Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-, Monohydrochloride
70. S3146
71. Akos015913800
72. N'-benzyl-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine Hydrochloride
73. Ccg-100816
74. Cs-1395
75. Nc00066
76. 1,2-ethanediamine, N1,n1-dimethyl-n2-(phenylmethyl)-n2-2-pyridinyl-, Hydrochloride (1:?)
77. Tripelennamine Hydrochloride [mi]
78. As-59347
79. Hy-17428
80. Db-043233
81. Tripelennamine Hydrochloride [mart.]
82. Tripelennamine Hydrochloride [vandf]
83. Ft-0631854
84. Sw197446-3
85. Tripelennamine Hydrochloride [usp-rs]
86. Tripelennamine Hydrochloride [who-dd]
87. D02091
88. D70467
89. Wln: T6nj Bn1r & 2n1 & 1 & Gh
90. Tripelennamine Hydrochloride [green Book]
91. Tripelennamine Hydrochloride, Analytical Standard
92. A809564
93. Tripelennamine Hydrochloride [orange Book]
94. Sr-01000003013-6
95. Sr-01000003013-7
96. Tripelennamine Hydrochloride [usp Monograph]
97. W-108029
98. Q27278242
99. Z1552027600
100. Ethylenediamine,n'-dimethyl-n-(2-pyridyl)-, Hydrochloride
101. Tripelennamine Hydrochloride 100 Microg/ml In Acetonitrile
102. 2-(benzyl(2-(dimethylamino)ethyl)amino)-pyridine Hydrochloride
103. 2-(benzyl(2-(dimethylamino)ethyl)amino)-pyridinhydrochloride
104. 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridinemonohydrochloride
105. 1, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, Monohydrochloride
106. N-[benzyl-n-(dimethylamino)ethyl] .alpha.-aminopyridine Hydrochloride
107. N-benzyl-n',n'-dimethyl-n-pyridin-2-ylethane-1,2-diamine Hydrochloride
108. N-benzyl-n-.alpha.-pyridyl-n',n'-dimethyl-aethylendiamin-hydrochlorid
109. 1,2-ethanediamine,n1,n1-dimethyl-n2-(phenylmethyl)-n2-2-pyridinyl-,hydrochloride
110. N(sup 1)-.alpha.-pyridyl-n(sup 1)-benzyl-n,n-dimethyl Ethylenediamine Monohydrochloride
111. N~1~-benzyl-n~2~,n~2~-dimethyl-n~1~-(2-pyridinyl)-1,2-ethanediamine Hydrochloride
112. Tripelennamine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
113. N'-benzyl-n,n-dimethyl-n'-(2-pyridyl)ethane-1,2-diamine Hydrochloride;tripelennamine Hydrochloride
Molecular Weight | 291.82 g/mol |
---|---|
Molecular Formula | C16H22ClN3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 291.1502254 g/mol |
Monoisotopic Mass | 291.1502254 g/mol |
Topological Polar Surface Area | 19.4 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 236 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tripelennamine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tripelennamine Hydrochloride, including repackagers and relabelers. The FDA regulates Tripelennamine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tripelennamine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tripelennamine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tripelennamine Hydrochloride supplier is an individual or a company that provides Tripelennamine Hydrochloride active pharmaceutical ingredient (API) or Tripelennamine Hydrochloride finished formulations upon request. The Tripelennamine Hydrochloride suppliers may include Tripelennamine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Tripelennamine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tripelennamine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Tripelennamine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Tripelennamine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Tripelennamine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tripelennamine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Tripelennamine Hydrochloride USDMF includes data on Tripelennamine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tripelennamine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tripelennamine Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tripelennamine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tripelennamine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tripelennamine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tripelennamine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tripelennamine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tripelennamine Hydrochloride suppliers with NDC on PharmaCompass.
Tripelennamine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tripelennamine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tripelennamine Hydrochloride GMP manufacturer or Tripelennamine Hydrochloride GMP API supplier for your needs.
A Tripelennamine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Tripelennamine Hydrochloride's compliance with Tripelennamine Hydrochloride specifications and serves as a tool for batch-level quality control.
Tripelennamine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Tripelennamine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tripelennamine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Tripelennamine Hydrochloride EP), Tripelennamine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tripelennamine Hydrochloride USP).
LOOKING FOR A SUPPLIER?